Ontology highlight
ABSTRACT: Background & aims
The intestinal immune system is tightly regulated to prevent responses against the many nonpathogenic antigens in the gut. Transforming growth factor (TGF)-? is a cytokine that maintains intestinal homeostasis, in part by inducing Foxp3(+) regulatory T cells (Tregs) that suppress immune responses. TGF-? is expressed at high levels in the gastrointestinal tract as a latent complex that must be activated. However, the pathways that control TGF-? activation in the intestine are poorly defined. We investigated the cellular and molecular pathways that control activation of TGF-? and induction of Foxp3(+) Tregs in the intestines of mice to maintain immune homeostasis.Methods
Subsets of intestinal dendritic cells (DCs) were examined for their capacity to activate TGF-? and induce Foxp3(+) Tregs in vitro. Mice were fed oral antigen, and induction of Foxp3(+) Tregs was measured.Results
A tolerogenic subset of intestinal DCs that express CD103 were specialized to activate latent TGF-?, and induced Foxp3(+) Tregs independently of the vitamin A metabolite retinoic acid. The integrin ?v?8, which activates TGF-?, was significantly up-regulated on CD103(+) intestinal DCs. DCs that lack expression of integrin ?v?8 had reduced ability to activate latent TGF-? and induce Foxp3(+) Tregs in vitro and in vivo.Conclusions
CD103(+) intestinal DCs promote a tolerogenic environment in the intestines of mice via integrin ?v?8-mediated activation of TGF-?.
SUBMITTER: Worthington JJ
PROVIDER: S-EPMC3507624 | biostudies-literature | 2011 Nov
REPOSITORIES: biostudies-literature
Worthington John J JJ Czajkowska Beata I BI Melton Andrew C AC Travis Mark A MA
Gastroenterology 20110630 5
<h4>Background & aims</h4>The intestinal immune system is tightly regulated to prevent responses against the many nonpathogenic antigens in the gut. Transforming growth factor (TGF)-β is a cytokine that maintains intestinal homeostasis, in part by inducing Foxp3(+) regulatory T cells (Tregs) that suppress immune responses. TGF-β is expressed at high levels in the gastrointestinal tract as a latent complex that must be activated. However, the pathways that control TGF-β activation in the intestin ...[more]